PRKAA2 and hepatocellular carcinoma: These findings demonstrate that TRPV4 activation promotes the metastasis of HCC in vivo, and GL-V9 effectively prevents HCC metastasis by inhibiting AMPK/MLC/ERM pathway implicated in sc polarity.